Eisai Co Ltd – ReportWire

FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage

[ad_1] The Food and Drug Administration on Thursday approved the Alzheimer’s treatment Leqembi, a pivotal decision that is expected to expand access to the expensive drug...

Breaking News2 years ago

FDA approves Alzheimer’s treatment Leqembi, clearing the way for Medicare coverage

[ad_1] The U.S. Food and Drug Administration on Thursday granted full approval to the Biogen BIIB and Eisai Co. Ltd. ESALF Alzheimer’s treatment Leqembi, a step...

Business2 years ago

Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease

[ad_1] Juanmonino | E+ | Getty Images Seniors with early Alzheimer’s disease will face major hurdles to get treated even if promising new drugs roll out...

Business2 years ago

Medicare rejects Alzheimer’s Association request for unrestricted coverage of treatments like Leqembi

[ad_1] Medicare will not provide broader coverage of the Alzheimer’s drug Leqembi until it receives more evidence that the treatment is reasonable and necessary, according to...

Business2 years ago

Stocks making the biggest moves premarket: Tesla, Nutanix, Meta and more

[ad_1] Check out the companies making headlines before the bell: Tesla (TSLA) – Tesla CEO Elon Musk said he would refrain from selling any more Tesla...